PRIMAPRED 20MG CP BOX OF 10

Conditions or diseases:

Collagen and connective tissue diseases: Progressive flares of systemic diseases, notably: systemic lupus erythematosus, vasculitis, polymyositis, visceral sarcoidosis.

Dermatological: Severe autoimmune blistering dermatoses, particularly pemphigus and bullous pemphigoid. Severe forms of infantile hemangiomas. Certain forms of lichen planus. Certain acute urticarias. Severe forms of neutrophilic dermatoses.

Digestive: Progressive flares of ulcerative colitis and Crohn’s disease. Autoimmune chronic active hepatitis (with or without cirrhosis). Severe acute alcoholic hepatitis, histologically proven.

Endocrine: Severe subacute thyroiditis of De Quervain. Certain hypercalcemias.

Hematological: Severe immune thrombocytopenic purpura. Autoimmune hemolytic anemia. In combination with various chemotherapies for the treatment of malignant lymphoid hematopathies. Chronic erythroblastopenia, acquired or congenital.

Infectious: Tuberculous pericarditis and severe forms of tuberculosis with life-threatening prognosis. Pneumocystis carinii pneumonia with severe hypoxia.

Neoplastic: Antiemetic treatment during antineoplastic chemotherapy. Edematous and inflammatory flares associated with antineoplastic treatments (radiotherapy and chemotherapy).

Nephrological: Nephrotic syndrome with minimal glomerular lesions. Nephrotic syndrome of primary focal segmental glomerulosclerosis. Stage III and IV lupus nephropathy. Intrarenal granulomatous sarcoidosis. Vasculitis with renal involvement. Primary extracapillary glomerulonephritis.

Neurological: Myasthenia. Tumor-related cerebral edema. Chronic idiopathic inflammatory polyradiculoneuritis. Infantile spasms (West syndrome), Lennox-Gastaut syndrome. Relapsing multiple sclerosis, following intravenous corticosteroid therapy.

Ophthalmological: Severe anterior and posterior uveitis. Edematous exophthalmos. Certain optic neuropathies, following intravenous corticosteroid therapy (in this indication, oral administration as first-line is not recommended).

ENT (Ear, Nose, Throat): Certain serous otitis. Nasosinusal polyposis. Certain acute or chronic sinusitis. Seasonal allergic rhinitis in short courses. Acute stridulous laryngitis (subglottic laryngitis) in children.

Respiratory: Persistent asthma, preferably in short courses in case of failure of high-dose inhaled treatment. Asthma exacerbations, particularly severe acute asthma. Chronic obstructive bronchopneumopathy for evaluation of reversibility of obstructive syndrome. Progressive sarcoidosis. Diffuse interstitial pulmonary fibrosis.

Rheumatological: Rheumatoid arthritis and certain polyarthritis. Polymyalgia rheumatica and Horton’s disease. Acute rheumatic fever. Severe and refractory cervicobrachial neuralgias.

Organ and hematopoietic stem cell transplantation: Prophylaxis or treatment of graft rejection. Prophylaxis or treatment of graft-versus-host disease.